Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Not applicableUnknownNCT03210090
What this trial is testing

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients

Who this might be right for
Cytomegalovirus InfectionHSCT
Maimónides Biomedical Research Institute of Córdoba 100
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Not applicableUnknownNCT00587574
What this trial is testing

Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Cell Transplant Recipients
Medical University of Vienna 150
Not applicableUnknownNCT06148610
What this trial is testing

Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support

Who this might be right for
Hematologic DiseasesBone Marrow TransplantationHematopoietic Stem Cell Transplantation
Fonds de Dotation HTC Project 170
Early research (Phase 1)Looking for participantsNCT03533816
What this trial is testing

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
University of Kansas Medical Center 38
Early research (Phase 1)Study completedNCT01497184
What this trial is testing

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 95
Not applicableStudy completedNCT01255449
What this trial is testing

Respiratory Impedance and Obliterative Bronchiolitis

Who this might be right for
Hematopoietic Stem Cell TransplantationObliterative Bronchiolitis
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 26
Early research (Phase 1)Ended earlyNCT05065047
What this trial is testing

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT01582048
What this trial is testing

Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Who this might be right for
Patients Receiving Mismatched Allogeneic HCT
Prof. Dr. med. Wolfgang Bethge 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05317416
What this trial is testing

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

Who this might be right for
Multiple Myeloma
Pfizer 854
Testing effectiveness (Phase 2)Study completedNCT05338047
What this trial is testing

Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

Who this might be right for
Myeloma MultipleLymphoma
Hospital Universitario Dr. Jose E. Gonzalez 30
Testing effectiveness (Phase 2)UnknownNCT01509300
What this trial is testing

HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromeSolid Tumors
Asan Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT04932564
What this trial is testing

Leflunomide for Musculoskeletal GVHD After Allogeneic Stem Cell Transplant

Who this might be right for
Musculoskeletal Disease OtherGVHD, Chronic
Tata Memorial Centre 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07734012
What this trial is testing

Mycophenolate After Stem Cell Transplant for Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)
Ottawa Hospital Research Institute 6
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00134017
What this trial is testing

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 142
Testing effectiveness (Phase 2)Looking for participantsNCT06802315
What this trial is testing

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia, Relapsed, AdultAcute Myeloid Leukemia RefractoryChronic Myeloid Leukemia - Accelerated Phase+1 more
University of Illinois at Chicago
Post-approval studies (Phase 4)Looking for participantsNCT06571825
What this trial is testing

RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

Who this might be right for
Acute Myeloid Leukemia
He Huang 118
Not applicableStudy completedNCT06734585
What this trial is testing

Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Singapore Pte. Ltd. 114
Next Page
38